| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-437X(95)90053-5 |
| P698 | PubMed publication ID | 7749326 |
| P2093 | author name string | McCormick F | |
| P2860 | cites work | Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients | Q34166560 |
| The regulation and function of p21ras in T cells | Q36286249 | ||
| Regulation of membrane turnover by ras proteins | Q39677635 | ||
| Von Recklinghausen neurofibromatosis | Q40262766 | ||
| Biochemical and biological properties of the human N-ras p21 protein | Q40658346 | ||
| Activators and effectors of ras p21 proteins | Q40757563 | ||
| MAP kinase kinase kinase, MAP kinase kinase and MAP kinase | Q40757575 | ||
| The neurofibromatosis type 1 gene | Q40890806 | ||
| Suppression of c-ras transformation by GTPase-activating protein | Q41205326 | ||
| Neurofibromatosis type 1 gene mutations in neuroblastoma | Q41579794 | ||
| Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis | Q42806305 | ||
| The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae | Q43515231 | ||
| Differential regulation of rasGAP and neurofibromatosis gene product activities | Q43668633 | ||
| The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids | Q45289350 | ||
| A putative Ras GTPase activating protein acts as a negative regulator of signaling by the Sevenless receptor tyrosine kinase | Q46204426 | ||
| Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders | Q46413091 | ||
| Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients | Q24294421 | ||
| Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus | Q24299756 | ||
| Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 | Q24309607 | ||
| The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins | Q24324729 | ||
| sar1, a gene from Schizosaccharomyces pombe encoding a protein that regulates ras1 | Q24595034 | ||
| Mammalian Ras interacts directly with the serine/threonine kinase Raf | Q27860833 | ||
| Bcl-2 associates with the ras-related protein R-ras p23 | Q28256068 | ||
| Proteins regulating Ras and its relatives | Q28257295 | ||
| Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase | Q28269621 | ||
| A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations | Q28300121 | ||
| The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 | Q28609120 | ||
| Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation | Q29616396 | ||
| Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane | Q29618478 | ||
| Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells | Q29618480 | ||
| Activation of Raf as a result of recruitment to the plasma membrane | Q29618481 | ||
| Phosphatidylinositol-3-OH kinase as a direct target of Ras | Q29620177 | ||
| Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. | Q33256073 | ||
| Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro | Q33292215 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 51-55 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | Ras signaling and NF1. | |
| P478 | volume | 5 |
| Q47072734 | A neurofibromatosis-1-regulated pathway is required for learning in Drosophila |
| Q77315281 | A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein |
| Q46292236 | Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease). |
| Q34253927 | Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway? |
| Q80063140 | Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing |
| Q24304570 | Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast |
| Q50671106 | Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia. |
| Q47620432 | Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases |
| Q28602124 | Genome-wide analysis reveals adaptation to high altitudes in Tibetan sheep |
| Q82452891 | Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway |
| Q47072868 | In vivo functional analysis of Drosophila Gap1: involvement of Ca2+ and IP4 regulation |
| Q33604218 | Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis |
| Q38563753 | Lessons from the p53 mutant mouse |
| Q64060975 | Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies |
| Q36497139 | MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. |
| Q41099828 | Mechanisms of carcinogenesis and the mutant mouse |
| Q104135136 | MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK |
| Q74736163 | Molecular genetics of renal cell carcinoma |
| Q33535727 | Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway |
| Q28279834 | Neurofibromatosis type 1: piecing the puzzle together |
| Q80604617 | Neurofibromatosis with gastrointestinal stromal tumors: insights into the association |
| Q52170341 | Neurofibromin progress on the fly. |
| Q79605117 | Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy |
| Q35944775 | Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation |
| Q36452994 | Polymorphism in the neurofibromin gene, Nf1, is associated with antagonistic selection on wing size and development time in Drosophila melanogaster |
| Q35987649 | Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1. |
| Q48057194 | Protein farnesyltransferase in plants: molecular characterization and involvement in cell cycle control |
| Q39856973 | Ral overactivation in malignant peripheral nerve sheath tumors |
| Q55477300 | Ras activation in astrocytomas and neurofibromas. |
| Q41101646 | Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively |
| Q37061120 | Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes |
| Q36373503 | Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. |
| Q40872114 | Signal transduction pathways and their relevance in human astrocytomas |
| Q77343239 | The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas |
| Q41462850 | Towards a unified model of tumor suppression: lessons learned from the human patched gene |
| Q28584833 | Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein |
Search more.